Latest News - Cataract Surgery

Monday, March 20, 2017 | Cataract Surgery, Medical Studies, Imprimis Pharmaceuticals

Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, today announced the publication of a dropless therapy article in the peer-reviewed journal, Current Pharmaceutical Desig…

Read the full story

Wednesday, February 22, 2017 | Cataract Surgery, Ocular Therapeutix

Ocular Therapeutix Announces FDA Acceptance of NDA Resubmission for Dextenza for the Treatment of Ocular Pain After Ophthalmic Surgery

Ocular Therapeutix announced that the company’s new drug application (NDA) resubmission for Dextenza (dexamethasone insert) 0.4 mg for intracanalicular use for the treatment of ocular pain occur…

Read the full story

Wednesday, January 04, 2017 | Cataract Surgery, Clinical Trials, Ocular Therapeutix

Ocular Therapeutix Announces Additional Successful Results for Phase 3 Clinical Trial of Dextenza

Ocular Therapeutix announced additional positive secondary endpoint results from its most recent successful phase 3 clinical trial of Dextenza (dexamethasone insert) 0.4 mg for the treatment of postsu…

Read the full story

Friday, December 02, 2016 | Cataract Surgery

Update on Zepto, The Disposable Capsulotomy Device

In this interview from AAO 2016, Dr. David Chang discusses his experience with Zepto (Mynosys Inc., Fremont, CA), an inexpensive and disposable capsulotomy device that uses low-energy pulses to create…

Read the full story

Friday, July 22, 2016 | Cataract Surgery, Medical Studies, Imprimis Pharmaceuticals

Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops

Imprimis Pharmaceuticals announced that positive results of a clinical study comparing the efficacy of its injected triamcinolone acetonide, moxifloxacin hydrochloride, and vancomycin (Tri-Moxi-Vanc) …

Read the full story

Monday, July 11, 2016 | Cataract Surgery, Health Care

Health Tourists Jump Queue for Cataract Operations on NHS as British Patients Wait up to 8 Months

Health tourists are being given cataract surgery on the NHS ahead of British patients because their conditions are considered more of a priority, it has emerged. Hundreds of people from countries incl…

Read the full story

Wednesday, June 29, 2016 | Cataract Surgery, Partnerships

Harman and HelpMeSee Partner to Reduce Blindness on a Global Scale

Harman announced its role in developing an enterprise software solution for simulation-based training management with HelpMeSee, the global campaign to end cataract blindness. This Training Management…

Read the full story

Wednesday, June 01, 2016 | Cataract Surgery, Clinical Trials, Eyegate Pharmaceuticals

EyeGate Announces Interim Data from Clinical Trial of EGP-437 for Treatment of Inflammation and Pain After Cataract Surgery

EyeGate Pharmaceuticals announced interim data from its phase 1b/2a trial evaluating its lead product candidate, iontophoretic EGP-437, in the treatment of ocular inflammation and pain in cataract sur…

Read the full story

Tuesday, May 10, 2016 | Cataract Surgery, Medical Studies

Femtosecond Laser Could Help in Challenging Cataract Cases

Cataract patients with shallow anterior chambers who were treated with femtosecond laser-assisted cataract surgery had less anterior chamber inflammation and less corneal edema the day after surgery t…

Read the full story

Thursday, March 24, 2016 | Cataract Surgery, Medical Studies, American Academy of Ophthalmology

Eating Foods High in Vitamin C Cuts Risk of Cataract Progression by a Third

A new study shows that a diet rich in vitamin C helps slow the progression of cataracts. The research also shows for the first time that diet and lifestyle may play a greater role than genetics in cat…

Read the full story

Thursday, March 17, 2016 | Cataract Surgery, Partnerships, Acucela

Acucela Secures Option to Exclusively License Non-Surgical Cataract Treatment

Acucela and YouHealth Eyetech announced an agreement involving an exclusive option from YouHealth on lanosterol technology licensed from the Regents of the University of California, San Diego for the …

Read the full story

Tuesday, March 01, 2016 | Cataract Surgery, Clinical Trials, Presbia

First Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits

Presbia announced that all subjects treated as part of the first stage of its FDA pivotal study completed their 12-month postoperative visits, a milestone in the FDA approval process of its Presbia Fl…

Read the full story

Thursday, February 04, 2016 | Cataract Surgery, FDA Approval/Clearance, Oculus

The Oculus Pentacam AXL with Optical Biometry Receives FDA Clearance

The new Oculus Pentacam AXL has received 510(k) clearance from the FDA. The device is capable of anterior segment tomography and optical biometry with a single measuring operation, according to a comp…

Read the full story

Wednesday, December 16, 2015 | Cataract Surgery, Clinical Trials, ReVision Optics

Clinical Data from ReVision Optics’ Raindrop Near Vision Inlay Featured in Two Presentations

ReVision Optics announced that clinical data from its Raindrop Near Vision Inlay for the treatment of presbyopia was the subject of two presentations at the 2015 OIS@AAO conference, held last month in…

Read the full story

Tuesday, November 10, 2015 | Cataract Surgery, Truevision Systems

TrueVision Granted Fundamental Patent For Real-time Surgical Reference Indicium Apparatus and Methods for Intraocular Lens Implantation for Astigmatic Correction

TrueVision 3D Surgical announced it has been issued a patent by the US Patent & Trademark Office (USPTO) for fundamental technology underlying computer-guided methods for toric IOL placement and a…

Read the full story
Load More